Bayer Reports Positive Phase III Results for Inves...
Category : Clinical Trial Update 9 May 2026Bayer announced positive topline results from the Phase III REVEAL study evaluating I 124 evuzamitid...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Bayer announced positive topline results from the Phase III REVEAL study evaluating I 124 evuzamitid...
Mabwell announced that the US Food and Drug Administration has cleared the Investigational New Drug...
For the first time in more than 20 years, a randomized controlled trial has demonstrated significant...
Alebund Pharmaceuticals has completed patient enrollment in the global Phase III pivotal clinical tr...
Cardiol Therapeutics announced that results from its Phase II study evaluating CardiolRx in recurren...